Fidelity Investments
TLSI icon

Fidelity Investments’s TriSalus Life Sciences TLSI Stock Holding History

Fidelity Investments’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.26K Sell
1,316
-9,459
-88% -$46.3K ﹤0.01% 4906
2025
Q4 		$75.2K Buy
10,775
+10,519
+4,109% +$58.9K ﹤0.01% 3895
2025
Q3 		$1.19K Buy
+256
New +$1.2K ﹤0.01% 4999

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Fidelity Investments's TLSI Position: Q1 2026 in Review

Fidelity Investments reduced its TriSalus Life Sciences (TLSI) stake by 88% in Q1 2026, selling an estimated $46.3K and leaving 1,316 shares worth $5.26K. The position accounts for ﹤0.01% of the portfolio, ranked #4906.

Fidelity Investments first reported a position in TLSI in Q3 2025 and has held it in 3 quarters since. The position peaked at $75.2K in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Fidelity Investments held 1,316 shares of TriSalus Life Sciences worth $5.26K as of Q1 2026.
  • Fidelity Investments sold 9,459 TriSalus Life Sciences shares in Q1 2026, an estimated $46.3K.
  • TriSalus Life Sciences made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4906 holding.
  • Fidelity Investments first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • Fidelity Investments's TriSalus Life Sciences position peaked at $75.2K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.